Subscribe

Patrick McGann, MD, MS

Articles by Patrick McGann, MD, MS

Stem Cell vs Gene Therapy Processes in Sickle Cell Disease

ByIfeyinwa (Ify) Osunkwo, MD, MPH, Atrium Health,Abdullah Kutlar, MD, Augusta University,Patrick McGann, MD, MS ,Wally Smith, MD

May 26th 2021

A discussion of the course of gene therapy compared with stem cell therapy.

Emerging Gene Therapy Methods in SCD

ByIfeyinwa (Ify) Osunkwo, MD, MPH, Atrium Health,Abdullah Kutlar, MD, Augusta University,Patrick McGann, MD, MS ,Wally Smith, MD

May 19th 2021

Experts review data around emerging gene therapy approaches in sickle cell disease.

Gene Therapy Approaches in SCD

ByIfeyinwa (Ify) Osunkwo, MD, MPH, Atrium Health,Abdullah Kutlar, MD, Augusta University,Wally Smith, MD ,Patrick McGann, MD, MS

May 19th 2021

An overview of gene therapy in sickle cell disease as well as clinical trials underway in the space.

Latest Updated Articles

Trending on CGTlive®

Krystal Biotech’s Neurotrophic Keratitis Gene Therapy Viral Vector Secures FDA Platform Technology Designation

FDA Picks Abeona’s XLRS Gene Therapy ABO-503 for RDEA Pilot Program

Around the Helix: Cell and Gene Therapy Company Updates – October 15, 2025

Tr1X's Multiple Sclerosis Cell Therapy TRX319 Cleared for US Trial

BLA for Rocket’s LAD-I Gene Therapy Under Review by FDA Again

© 2025 MJH Life Sciences^®

All rights reserved.